U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 18-24, 2019
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 18-24, 2019

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

No Significant Event

Official Name: Amy Abernethy, M.D., Ph.D., Principal Deputy Commissioner

No Significant Event

Official Name: Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name: Lowell J. Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 08/19/2019
Location: Silver Spring, MD
Subject: Meet and Greet: Food Safety Issues
FDA Participant/Group: TRACEY SANDERS; KARI BARRETT; LARRY MORRIS;
Non FDA Participant/Group: Brad Figel (Mars, Incorporate); Tom Langan (Unilever); Cathy Cochran (Glover Park Group); Molly Fogarty (Nestle); Chris Adamo (Danone North America Public Benefit Corporation);

Event Date: 08/20/2019
Location: Silver Spring, MD
Subject: Food Safety and Supply Chain Issues
FDA Participant/Group: NINA ZIMDAHL;
Non FDA Participant/Group: Carletta Ooton (Amazon);

Event Date: 08/23/2019
Location: Washington, DC
Subject: Palantir Technologies Introduction and Food Safety
FDA Participant/Group: CAITLIN BOON; CHARLES PASTEL;
Non FDA Participant/Group: Cobi Blumenfeld-Gantz, Eliana Schleifer, Ethan Wilkes, Julie Bush, Victoria Lauredo (Palantir);

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

Event Date: 08/21/2019
Location: Silver Spring, Maryland
Subject: Meeting with Campaign for Tobacco-Free Kids on ENDS Advertising
FDA Participant/Group: PERHAM GORJI; KELLEY NDUOM; GRAIL SIPES; DAVID MARKERT; DIANA KANEVA; PAIGE TAYLOR; DAVID MEDNICK; MITCHELL ZELLER; ANN SIMONEAU; MICHELE MITAL; LINDA EPSTEIN; AMANDA EDMONDS; ROBERT BERLIN; SARA BEARDSLEY; CLAUDIA AHIABOR;
Non FDA Participant/Group: Dennis Henigan , Swati Rawani (Campaign for Tobacco Free Kids); Andrew Goldfarb, William B. Schultz (Zuckerman Spaeder LLP);